Photo by rawpixel on Unsplash

Healthcare in Nigeria is plagued with several challenges. There’s a low doctor to patient ratio, 1:5100, and a lack of hospital beds, 5 beds per 10,000 people. The challenges are well documented with far-reaching consequences. Maternal mortality in Nigeria remains one of the highest in the world, with 800 deaths for every 100,000 live births.

Within the past decade, there has been an emergence of health entrepreneurs who are using technology and the internet to address some of the nation’s health problems. We are putting together a map and analysis of the health sector that examines the healthcare landscape and the solutions that these healthtech innovators are bringing to bear on the problems of access to quality and affordable healthcare in Nigeria.

If you are innovating around the healthcare space in Nigeria, we would like to hear from you.

Our goal is to ensure that we paint an accurate picture of the healthtech sector and provide actionable insights for investors, policymakers and healthtech entrepreneurs. Sign up here before November 30 to help us learn about your startup and to join us in achieving this goal.

Read this next
More From TC

On Thursday, July 11, 2019, TechCabal hosted its second townhall of 2019 to discuss the importance of renewable energy to Africa for improving access to electricity. The event also highlighted the challenges that exist in the renewable energy market and how they should be addressed.

Some of China’s Most Innovative Companies are now backing Nigeria’s OPay
Business, FinTech, Funding, News, Ridesharing, startups, Technology, Venture Capital
15th July 2019

Nigeria-based OPay has closed a new $50 million funding round, the largest for any Nigerian tech startup so far in 2019. The company will use the new funding to deepen its roots in the Nigerian market for all its digital businesses including ORide and OFood. It also has plans to expand to other African markets.

TechCabal is a Big Cabal Media brand

Copyright © 2019
All rights reserved

Privacy & Terms